4821 Vaccine Adverse Reactions Over Three Days Until the 2nd... "Causality Unconfirmed" 16 Deaths

9 Cases of Anaphylaxis, 272 Cases of Major Adverse Reactions Increased

[Image source=Yonhap News]

[Asia Economy Reporter Lim Cheol-young] As COVID-19 vaccinations continue, the number of reported adverse reactions is also steadily increasing.

According to the COVID-19 Vaccination Response Promotion Team on the 3rd, a total of 4,821 cases suspected of adverse reactions were reported to health authorities over the three days from the 30th of last month to the 2nd.

By vaccine type, AstraZeneca accounted for 3,104 cases, Pfizer 1,173 cases, Janssen 458 cases, and Moderna 86 cases. By day, 1,691 cases were reported on the 30th of last month, 1,510 cases on the 1st, and 1,620 cases on the 2nd.

There were 16 reported deaths related to vaccination. Eight had received AstraZeneca, seven Pfizer, and one Janssen. Among the deceased, 10 were male and 6 were female.

One female death was a woman in her 80s who died on the day of vaccination. The time from vaccination to death in this report ranged from 2 to 28 days, with five in their 60s, six in their 70s, and three in their 80s. One woman in her 90s and one man in his 30s also died. Among them, eight had underlying conditions, two did not, and the remaining six are under investigation.

There were nine additional suspected reports of anaphylaxis, a severe systemic allergic reaction. Six cases were after Pfizer vaccination and three after Moderna. There were 272 newly confirmed cases of 'special interest adverse reactions,' including ICU admissions, life-threatening conditions, permanent disabilities, and sequelae. The rest were general adverse reactions such as fever and headache.

Meanwhile, the cumulative number of suspected adverse reaction reports has reached 94,549, which is about 0.49% of the total first and second dose vaccinations. Health authorities release adverse reaction report statistics three times a week on Mondays, Wednesdays, and Saturdays.

This content was produced with the assistance of AI translation services.